vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and ISABELLA BANK CORP (ISBA). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $21.2M, roughly 1.8× ISABELLA BANK CORP). CODEXIS, INC. runs the higher net margin — 24.7% vs 22.2%, a 2.5% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 14.3%). ISABELLA BANK CORP produced more free cash flow last quarter ($23.3M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 12.6%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

The Bank of the Philippine Islands is a universal bank in the Philippines. It is the oldest bank in both the Philippines and Southeast Asia. It is the fourth largest bank in terms of assets, the second largest bank in terms of market capitalization, and one of the most profitable banks in the Philippines.

CDXS vs ISBA — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.8× larger
CDXS
$38.9M
$21.2M
ISBA
Growing faster (revenue YoY)
CDXS
CDXS
+67.1% gap
CDXS
81.3%
14.3%
ISBA
Higher net margin
CDXS
CDXS
2.5% more per $
CDXS
24.7%
22.2%
ISBA
More free cash flow
ISBA
ISBA
$3.8M more FCF
ISBA
$23.3M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
12.6%
ISBA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
ISBA
ISBA
Revenue
$38.9M
$21.2M
Net Profit
$9.6M
$4.7M
Gross Margin
94.8%
Operating Margin
27.1%
32.2%
Net Margin
24.7%
22.2%
Revenue YoY
81.3%
14.3%
Net Profit YoY
192.5%
17.4%
EPS (diluted)
$0.13
$0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
ISBA
ISBA
Q4 25
$38.9M
$21.2M
Q3 25
$8.6M
$20.5M
Q2 25
$15.3M
$18.8M
Q1 25
$7.5M
$18.1M
Q4 24
$21.5M
$18.5M
Q3 24
$12.8M
$18.0M
Q2 24
$8.0M
$17.2M
Q1 24
$17.1M
$16.7M
Net Profit
CDXS
CDXS
ISBA
ISBA
Q4 25
$9.6M
$4.7M
Q3 25
$-19.6M
$5.2M
Q2 25
$-13.3M
$5.0M
Q1 25
$-20.7M
$3.9M
Q4 24
$-10.4M
$4.0M
Q3 24
$-20.6M
$3.3M
Q2 24
$-22.8M
$3.5M
Q1 24
$-11.5M
$3.1M
Gross Margin
CDXS
CDXS
ISBA
ISBA
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
ISBA
ISBA
Q4 25
27.1%
32.2%
Q3 25
-220.3%
30.7%
Q2 25
-83.9%
32.8%
Q1 25
-271.6%
26.9%
Q4 24
-34.2%
26.0%
Q3 24
-129.0%
21.3%
Q2 24
-284.9%
23.9%
Q1 24
-69.6%
21.8%
Net Margin
CDXS
CDXS
ISBA
ISBA
Q4 25
24.7%
22.2%
Q3 25
-228.1%
25.6%
Q2 25
-86.6%
26.7%
Q1 25
-274.3%
21.9%
Q4 24
-48.4%
21.6%
Q3 24
-160.8%
18.2%
Q2 24
-285.2%
20.3%
Q1 24
-67.4%
18.7%
EPS (diluted)
CDXS
CDXS
ISBA
ISBA
Q4 25
$0.13
$0.64
Q3 25
$-0.22
$0.71
Q2 25
$-0.16
$0.68
Q1 25
$-0.25
$0.53
Q4 24
$-0.12
$0.54
Q3 24
$-0.29
$0.44
Q2 24
$-0.32
$0.46
Q1 24
$-0.16
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
ISBA
ISBA
Cash + ST InvestmentsLiquidity on hand
$78.2M
$26.0M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$231.4M
Total Assets
$147.8M
$2.2B
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
ISBA
ISBA
Q4 25
$78.2M
$26.0M
Q3 25
$58.7M
$161.3M
Q2 25
$66.3M
$108.6M
Q1 25
$59.8M
$69.2M
Q4 24
$73.5M
$24.5M
Q3 24
$90.3M
$27.4M
Q2 24
$73.2M
$23.6M
Q1 24
$85.5M
$25.2M
Total Debt
CDXS
CDXS
ISBA
ISBA
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
ISBA
ISBA
Q4 25
$50.5M
$231.4M
Q3 25
$38.5M
$227.4M
Q2 25
$55.6M
$220.5M
Q1 25
$49.6M
$215.6M
Q4 24
$66.9M
$210.3M
Q3 24
$73.4M
$213.0M
Q2 24
$61.4M
$202.2M
Q1 24
$79.3M
$200.7M
Total Assets
CDXS
CDXS
ISBA
ISBA
Q4 25
$147.8M
$2.2B
Q3 25
$124.0M
$2.3B
Q2 25
$138.2M
$2.2B
Q1 25
$128.9M
$2.1B
Q4 24
$149.0M
$2.1B
Q3 24
$148.2M
$2.1B
Q2 24
$132.0M
$2.1B
Q1 24
$149.6M
$2.1B
Debt / Equity
CDXS
CDXS
ISBA
ISBA
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
ISBA
ISBA
Operating Cash FlowLast quarter
$20.1M
$26.8M
Free Cash FlowOCF − Capex
$19.6M
$23.3M
FCF MarginFCF / Revenue
50.3%
110.2%
Capex IntensityCapex / Revenue
1.3%
16.4%
Cash ConversionOCF / Net Profit
2.09×
5.72×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$36.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
ISBA
ISBA
Q4 25
$20.1M
$26.8M
Q3 25
$-7.7M
$2.7M
Q2 25
$-18.0M
$7.8M
Q1 25
$-13.8M
$4.7M
Q4 24
$-16.5M
$19.6M
Q3 24
$-13.0M
$3.6M
Q2 24
$-12.2M
$5.5M
Q1 24
$-7.8M
$3.4M
Free Cash Flow
CDXS
CDXS
ISBA
ISBA
Q4 25
$19.6M
$23.3M
Q3 25
$-7.9M
$1.7M
Q2 25
$-20.5M
$7.2M
Q1 25
$-15.1M
$3.7M
Q4 24
$-18.2M
$17.5M
Q3 24
$-14.0M
$3.2M
Q2 24
$-12.6M
$5.1M
Q1 24
$-8.9M
$2.6M
FCF Margin
CDXS
CDXS
ISBA
ISBA
Q4 25
50.3%
110.2%
Q3 25
-91.7%
8.5%
Q2 25
-133.6%
38.5%
Q1 25
-199.6%
20.6%
Q4 24
-85.0%
94.6%
Q3 24
-109.0%
17.7%
Q2 24
-157.5%
29.8%
Q1 24
-52.2%
15.7%
Capex Intensity
CDXS
CDXS
ISBA
ISBA
Q4 25
1.3%
16.4%
Q3 25
2.1%
5.0%
Q2 25
16.4%
3.2%
Q1 25
16.7%
5.5%
Q4 24
8.3%
11.4%
Q3 24
7.8%
2.0%
Q2 24
5.0%
2.4%
Q1 24
6.6%
4.9%
Cash Conversion
CDXS
CDXS
ISBA
ISBA
Q4 25
2.09×
5.72×
Q3 25
0.52×
Q2 25
1.56×
Q1 25
1.19×
Q4 24
4.91×
Q3 24
1.08×
Q2 24
1.59×
Q1 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons